Loading company…
Riskpilot
← Back to search
Sign in
Get full access
RAB DIAGNOSTICS AS
AS
Active
Org 932079712
Ullernchausséen 64, 0379 Oslo
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2023
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 325K
EBITDA margin
-35.0%
-4161% vs 2023
Equity ratio
-138.5%
Financial strength
Net profit 2024
NOK -114K
-4161% vs 2023
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 325K
—
EBITDA
NOK -114K
-4161%
Net profit
NOK -114K
-4161%
Total assets
NOK 66K
+172%
Equity
NOK -92K
-523%
Employees
0
—
Company information
Legal name
RAB DIAGNOSTICS AS
Org number
932079712
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
15. september 2023
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Utvikle persontilpasset medisin samt investere og forvalte investeringer i selskaper med tilsvarende virksomhet.
Contact
Address
Ullernchausséen 64, 0379 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
0
325
Staff expenses
−0
−1
EBITDA
−3
−114
Depreciation & amort.
−0
−0
EBIT
−3
−114
Net financials
0
0
Profit before tax
−3
−114
Tax
−0
−0
Net profit
−3
−114
Balance sheet
NOK thousands
Item
2023
2024
Total assets
24
66
Equity
22
−92
Long-term debt
0
0
Short-term debt
3
158
Total debt
3
158
Financial ratios
5-year trend
EBITDA margin
-35.0%
This company
15.8%
Market median
-322% vs market
2023
2024
Equity ratio
-138.5%
This company
38.2%
Market median
-463% vs market
2023
2024
Return on equity
-11377100.0%
This company
18.4%
Market median
-61832165% vs market
2023
2024
Net profit margin
-35.0%
This company
8.1%
Market median
-532% vs market
2023
2024
Asset turnover
4.89×
This company
1.12×
Market median
+337% vs market
2023
2024
Debt / equity
1.72×
This company
0.62×
Market median
-177% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
AW
Anette Weyergang
Chief Executive Officer
Chief Executive Officer
2024
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
OE
Olav Engebråten
Board of Directors
2023
—
—
AM
Anne Mathilde Henden Kvamme
Board of Directors
2023
—
—
EM
Erling Magnus Hærem Sundrehagen
Board of Directors
2023
—
—
OJ
Ole Jesper Dahlberg
Board of Directors
2024
—
—
AK
Alf Kristian Berg
Board of Directors
2023
—
—
ØK
Øyvind Kongstun Arnesen
Chairman
2023
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Innoweyer As
Company
50.0%
50.0%
2024
Kb Lysovate As
Company
25.0%
25.0%
2024
Engeforsk Invest As
Company
25.0%
25.0%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Engeforsk Invest As
RAB DIAGNOSTICS AS
(this company)
Board network connections
Board members of RAB DIAGNOSTICS AS also hold positions in
0
other companies.
Person
Role here
Other companies
Anette Weyergang
Chief Executive Officer
0 companies
Olav Engebråten
Board of Directors
0 companies
Anne Mathilde Henden Kvamme
Board of Directors
0 companies
Erling Magnus Hærem Sundrehagen
Board of Directors
0 companies
Ole Jesper Dahlberg
Board of Directors
0 companies
Alf Kristian Berg
Board of Directors
0 companies
Øyvind Kongstun Arnesen
Chairman
0 companies